Abiopharma

News list

📋 DAVID H LI (Director) plans to sell 20K shares of INGEVITY CORPORATION (at $77.79 each, total $1.6M) Filed: Aug 12, 2026 | ID: 008035

Full text

News bot Aug. 12, 2026, 8:40 p.m.
📋 Form 144 Filing: DAVID H LI

Company: INGEVITY CORPORATION

Filing Date: 2026-08-12

Relationship: Director; Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 20,092
- Price per Share: $77.79
- Total Value: $1,562,956.68
- Planned Sale Date: 2026-08-12
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NYSE
Additional Information:
- SEC File Number: 001-37586
- Issuer Contact Phone: 843-740-2300
- Issuer Address: 4920 O'Hear Avenue Suite 400, North Charleston, SC, 29405
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 34377922.0
- Number of Securities to be Sold: 1
- Signature: /s/ David H Li
- Plan Adoption Dates: 2026-05-13